Patrick Jean-Philippe Selected Research

HIV Infections (HIV Infection)

1/2021	Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.
1/2021	Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
10/2019	Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.
1/2017	CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection.
10/2010	Antiretroviral treatment for children with peripartum nevirapine exposure.
8/2010	Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Jean-Philippe Research Topics

Disease

7	Tuberculosis (Tuberculoses) 07/2023 - 07/2011
6	HIV Infections (HIV Infection) 01/2021 - 08/2010
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2017
3	Meningococcal Infections 09/2017 - 01/2012
2	Viremia 01/2023 - 01/2021
2	Neutropenia 01/2021 - 11/2008
2	Infections 11/2019 - 07/2011
2	Body Weight (Weight, Body) 12/2011 - 07/2011
2	Disease Progression 11/2008 - 02/2002
1	Weight Gain 01/2024
1	Congenital Abnormalities (Deformity) 01/2023
1	Perinatal Death 01/2021
1	Clinical Deterioration 10/2020
1	Liver Failure 10/2019
1	Coinfection 01/2019
1	Malaria 01/2018
1	Parasitemia 01/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 06/2015
1	Anemia 11/2008
1	Exanthema (Rash) 11/2007
1	Chickenpox 11/2007
1	Pneumonia (Pneumonitis) 11/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2007

Drug/Important Bio-Agent (IBA)

4	Nevirapine (Viramune)FDA Link 01/2021 - 10/2010
3	efavirenz (Sustiva)FDA Link 01/2022 - 01/2017
3	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022 - 01/2017
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 07/2011
3	NucleosidesIBA 01/2018 - 05/2007
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 05/2007
3	Conjugate VaccinesIBA 09/2017 - 08/2010
2	RacivirIBA 01/2024 - 12/2011
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Ritonavir (Norvir)FDA Link 10/2020 - 01/2018
2	Lopinavir FDA Link 10/2020 - 01/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2023
1	Broadly Neutralizing AntibodiesIBA 01/2023
1	CreatinineIBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	dolutegravirIBA 01/2021
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021
1	FumaratesIBA 01/2021
1	Emtricitabine (Emtriva)FDA Link 01/2021
1	tenofovir alafenamideIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	butyl phosphorotrithioate (DEF)IBA 10/2020
1	HIV Protease InhibitorsIBA 01/2018
1	Fc Receptors (Fc Receptor)IBA 06/2013
1	Immunoglobulin G (IgG)IBA 06/2013
1	Mannose (D-Mannose)IBA 06/2013
1	Interleukin-10 (Interleukin 10)IBA 06/2013
1	Toll-Like Receptor 2IBA 06/2013
1	BCG Vaccine FDA Link 07/2011
1	Stavudine (Zerit)FDA LinkGeneric 11/2008
1	Zidovudine (Retrovir)FDA LinkGeneric 11/2008
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 11/2007
1	VaccinesIBA 11/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2011
1	Art Therapy 01/2021
1	Duration of Therapy 06/2015
1	Secondary Prevention 11/2008
1	Highly Active Antiretroviral Therapy (HAART) 02/2002